Locus Fermentation Solutions (Locus FS), a prominent green tech company specializing in sustainable alternatives to chemicals, has announced the expansion of its operational facilities by an additional 100,000 square feet. This expansion includes the creation of two cutting-edge biomanufacturing centers in Solon, Ohio. With this expansion, Locus FS aims to triple its biological production capacity, supporting worldwide efforts in decarbonization across critical sectors.
Locus FS, under the leadership of Chairman and CEO Andrew Lefkowitz, recognizes the increasing demand for sustainable biological innovations and carbon-neutral biomanufacturing. The company is committed to leading the charge in developing solutions that aid its partners in achieving their decarbonization and profitability objectives.
By expanding its operational footprint, Locus FS solidifies its role as a leading supplier of biological alternatives that outperform traditional chemicals and contribute to the decarbonization of vital global sectors such as agriculture, oil and gas, mining, consumer packaged goods (CPG), and industrial applications.
The expanded production capacity allows Locus FS to cater to the needs of its esteemed distribution partners, including Dow. Both biomanufacturing campuses feature low-carbon technologies that not only reduce environmental impact but also offer substantial cost and energy savings.
Scott Weber, Vice President of Production at Locus FS, highlights the efficiency of the company’s patented fermentation process. Unlike traditional manufacturing methods that can take years to scale up production, Locus FS can meet growing demand within just nine months. Although this expansion represents phase one of their plans, the new facilities have the potential capacity to produce an annual output of 2.5 million kilograms of biosurfactants in the future.
The recent Executive Order on Biotechnology and Biomanufacturing Innovation issued by the Biden administration underscores the need for increased domestic biological production. Locus FS stands as a solution to strengthen national biomanufacturing capacity, effectively addressing the demand for expanded capabilities.
Backed by more than 1,400 patent filings and over $250 million in funding, including a recent $117 million debt financing based on the value of its intellectual property, Locus FS is well-positioned to deliver on its expansion plans. The funds were used, in part, to support the establishment of state-of-the-art fermentation facilities.
The expansion of Locus FS’s biomanufacturing capabilities not only contributes to the company’s growth but also aligns with global efforts to achieve sustainable and environmentally friendly practices. By providing superior biological alternatives to harmful chemicals, Locus FS is driving innovation and accelerating the transition toward a greener future. As the demand for sustainable solutions continues to rise, Locus FS’s expanded facilities will play a crucial role in meeting these needs and supporting the worldwide decarbonization agenda.
Image provided by Locus Fermentation Solutions
2 Comments